Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis

被引:0
作者
Qiao Liu
Chenyuan Qin
Min Liu
Jue Liu
机构
[1] Peking University,Department of Epidemiology and Biostatistics, School of Public Health
[2] Peking University,Institute for Global Health and Development
来源
Infectious Diseases of Poverty | / 10卷
关键词
SARS-CoV-2; Vaccine; Effectiveness; Safety; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 712 条
[1]  
Barranco R(2021)Controversies and challenges of mass vaccination against SARS-CoV-2 in Italy: medico-legal perspectives and considerations Healthcare (Basel) 9 e20-e21
[2]  
Rocca G(2021)New variant of SARS-CoV-2 in UK causes surge of COVID-19 Lancet Respir Med 589 500-501
[3]  
Molinelli A(2021)Fast-spreading COVID variant can elude immune responses Nature 48 102-106
[4]  
Ventura F(2021)How the Delta variant achieves its ultrafast spread Nature 10 94-982
[5]  
Kirby T(2021)The challenge of emerging SARS-CoV-2 mutants to vaccine development J Genet Genomics 11 959-679
[6]  
Callaway E(2021)Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials Infect Dis Poverty 8 674-189
[7]  
Reardon S(2021)Safety and effectiveness of SARS-CoV-2 vaccines: a systematic review and meta-analysis J Med Virol 70 187-2465
[8]  
Li R(2021)Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials Vaccines (Basel) 385 2457-401
[9]  
Liu J(2021)Development and implementation of a potential coronavirus disease 2019 (COVID-19) vaccine: a systematic review and meta-analysis of vaccine clinical trials Nepal J Epidemiol 325 3698-643
[10]  
Zhang H(2020)Safety, tolerability, and immunogenicity of COVID-19 vaccines: a systematic review and meta-analysis medRxiv 12 396-1423